Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

Clinical trial NCT00319618 · COMPLETED

Trial details

NCT number: NCT00319618
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2003-06-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.